GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets

by Nada H. Hussein, Nada S. Amin, Hend M. El Tayebi
Published 2020-12-01

Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

by Sara M. Atwa, Margarete Odenthal, Hend M. El Tayebi
Published 2021-08-01

XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients

by Esraa A. Salama, Reda E. Adbeltawab, Hend M. El Tayebi
Published 2020-01-01

Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?

by Sawsan Elgohary, Aya A. Elkhodiry, Nada S. Amin, Ulrike Stein, Hend M. El Tayebi
Published 2021-02-01

Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma

by Amr A. Waly, Nada El-Ekiaby, Reem A. Assal, Mohamed M. Abdelrahman, Karim A. Hosny, Hend M. El Tayebi, Gamal Esmat, Kai Breuhahn, Ahmed I. Abdelaziz, Ahmed I. Abdelaziz
Published 2019-01-01